abbey chemists ltd Company Information
Company Number
SC323221
Website
www.abbeychemist.co.ukRegistered Address
c/o alexander sloan, 7th floor,, st. vincent street, glasgow, G2 5SG
Industry
Dispensing chemist in specialised stores
Telephone
01418893377
Next Accounts Due
March 2025
Group Structure
View All
Shareholders
asgher mohammed 49.9%
imran mohammed 19.9%
View Allabbey chemists ltd Estimated Valuation
Pomanda estimates the enterprise value of ABBEY CHEMISTS LTD at £1.5m based on a Turnover of £5.3m and 0.27x industry multiple (adjusted for size and gross margin).
abbey chemists ltd Estimated Valuation
Pomanda estimates the enterprise value of ABBEY CHEMISTS LTD at £0 based on an EBITDA of £-22k and a 3.8x industry multiple (adjusted for size and gross margin).
abbey chemists ltd Estimated Valuation
Pomanda estimates the enterprise value of ABBEY CHEMISTS LTD at £9m based on Net Assets of £4m and 2.27x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Abbey Chemists Ltd AI Business Plan
In just minutes, we combine Pomanda’s company and industry data with cutting edge Artificial Intelligence to build a comprehensive 27 section business plan. You then have 60 days to tailor the information, decide which sections to include or exclude, and add your own branding logos, images and color scheme to create your perfect plan.
Abbey Chemists Ltd Overview
Abbey Chemists Ltd is a live company located in glasgow, G2 5SG with a Companies House number of SC323221. It operates in the dispensing chemist in specialised stores sector, SIC Code 47730. Founded in May 2007, it's largest shareholder is asgher mohammed with a 49.9% stake. Abbey Chemists Ltd is a established, mid sized company, Pomanda has estimated its turnover at £5.3m with high growth in recent years.
Upgrade for unlimited company reports & a free credit check
Abbey Chemists Ltd Health Check
Pomanda's financial health check has awarded Abbey Chemists Ltd a 4.5 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 5 areas for improvement. Company Health Check FAQs
4 Strong
3 Regular
5 Weak
Size
annual sales of £5.3m, make it smaller than the average company (£12.2m)
- Abbey Chemists Ltd
£12.2m - Industry AVG
Growth
3 year (CAGR) sales growth of 16%, show it is growing at a faster rate (5.4%)
- Abbey Chemists Ltd
5.4% - Industry AVG
Production
with a gross margin of 30.9%, this company has a comparable cost of product (30.9%)
- Abbey Chemists Ltd
30.9% - Industry AVG
Profitability
an operating margin of -5.8% make it less profitable than the average company (2.2%)
- Abbey Chemists Ltd
2.2% - Industry AVG
Employees
with 41 employees, this is below the industry average (87)
41 - Abbey Chemists Ltd
87 - Industry AVG
Pay Structure
on an average salary of £22.7k, the company has an equivalent pay structure (£22.7k)
- Abbey Chemists Ltd
£22.7k - Industry AVG
Efficiency
resulting in sales per employee of £129.3k, this is equally as efficient (£139.8k)
- Abbey Chemists Ltd
£139.8k - Industry AVG
Debtor Days
it gets paid by customers after 45 days, this is later than average (31 days)
- Abbey Chemists Ltd
31 days - Industry AVG
Creditor Days
its suppliers are paid after 78 days, this is slower than average (67 days)
- Abbey Chemists Ltd
67 days - Industry AVG
Stock Days
it holds stock equivalent to 40 days, this is more than average (31 days)
- Abbey Chemists Ltd
31 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 60 weeks, this is more cash available to meet short term requirements (16 weeks)
60 weeks - Abbey Chemists Ltd
16 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 25.4%, this is a lower level of debt than the average (60.6%)
25.4% - Abbey Chemists Ltd
60.6% - Industry AVG
abbey chemists ltd Credit Report and Business Information
Abbey Chemists Ltd Competitor Analysis
Perform a competitor analysis for abbey chemists ltd by selecting its closest rivals and benchmarking them against 12 key performance metrics.
abbey chemists ltd Ownership
ABBEY CHEMISTS LTD group structure
Abbey Chemists Ltd has no subsidiary companies.
Ultimate parent company
ABBEY CHEMISTS LTD
SC323221
abbey chemists ltd directors
Abbey Chemists Ltd currently has 4 directors. The longest serving directors include Mr Asgher Mohammed (May 2007) and Ms Farzana Mohammed (May 2007).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Asgher Mohammed | 63 years | May 2007 | - | Director | |
Ms Farzana Mohammed | 64 years | May 2007 | - | Director | |
Mr Siraj Mohammed | Scotland | 36 years | Dec 2012 | - | Director |
Dr Imran Mohammed | Scotland | 39 years | Dec 2012 | - | Director |
ABBEY CHEMISTS LTD financials
Abbey Chemists Ltd's latest turnover from June 2023 is estimated at £5.3 million and the company has net assets of £4 million. According to their latest financial statements, Abbey Chemists Ltd has 41 employees and maintains cash reserves of £1.5 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 | Jun 2016 | Jun 2015 | Jun 2014 | Jun 2013 | Jun 2012 | Jun 2011 | Jun 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | ||||||||||||||
Other Income Or Grants | ||||||||||||||
Cost Of Sales | ||||||||||||||
Gross Profit | ||||||||||||||
Admin Expenses | ||||||||||||||
Operating Profit | ||||||||||||||
Interest Payable | ||||||||||||||
Interest Receivable | ||||||||||||||
Pre-Tax Profit | ||||||||||||||
Tax | ||||||||||||||
Profit After Tax | ||||||||||||||
Dividends Paid | ||||||||||||||
Retained Profit | ||||||||||||||
Employee Costs | ||||||||||||||
Number Of Employees | 41 | 43 | 40 | 41 | 40 | 37 | 34 | 37 | ||||||
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 | Jun 2016 | Jun 2015 | Jun 2014 | Jun 2013 | Jun 2012 | Jun 2011 | Jun 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 380,425 | 450,078 | 393,427 | 120,126 | 164,820 | 149,712 | 54,991 | 41,260 | 36,186 | 64,371 | 91,521 | 106,079 | 128,716 | 110,120 |
Intangible Assets | 2,186,976 | 2,374,476 | 2,561,976 | 2,749,476 | 2,936,976 | 3,124,476 | 3,311,976 | 3,499,476 | 3,686,976 | 3,874,476 | 4,061,976 | 4,249,476 | 4,500,000 | 4,500,000 |
Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Fixed Assets | 2,567,401 | 2,824,554 | 2,955,403 | 2,869,602 | 3,101,796 | 3,274,188 | 3,366,967 | 3,540,736 | 3,723,162 | 3,938,847 | 4,153,497 | 4,355,555 | 4,628,716 | 4,610,120 |
Stock & work in progress | 407,084 | 307,598 | 339,724 | 296,557 | 303,611 | 211,571 | 189,675 | 143,629 | 168,205 | 175,919 | 172,716 | 163,078 | 168,485 | 159,439 |
Trade Debtors | 657,045 | 363,457 | 485,194 | 378,370 | 510,841 | 401,172 | 357,472 | 328,356 | 343,884 | 384,662 | 397,033 | 371,668 | 392,200 | 362,225 |
Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2,366 | 0 | 0 | 0 | 0 | 0 | 0 |
Misc Debtors | 214,028 | 184,474 | 236,695 | 176,543 | 187,173 | 94,962 | 84,335 | 98,187 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash | 1,465,286 | 1,488,661 | 1,474,807 | 2,228,902 | 927,483 | 641,990 | 538,414 | 331,212 | 302,185 | 205,962 | 63,087 | 232,102 | 99,385 | 30,592 |
misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 22,370 | 0 | 0 | 0 | 0 | 0 |
total current assets | 2,743,443 | 2,344,190 | 2,536,420 | 3,080,372 | 1,929,108 | 1,349,695 | 1,169,896 | 903,750 | 836,644 | 766,543 | 632,836 | 766,848 | 660,070 | 552,256 |
total assets | 5,310,844 | 5,168,744 | 5,491,823 | 5,949,974 | 5,030,904 | 4,623,883 | 4,536,863 | 4,444,486 | 4,559,806 | 4,705,390 | 4,786,333 | 5,122,403 | 5,288,786 | 5,162,376 |
Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Creditors | 790,232 | 631,939 | 721,624 | 606,865 | 472,469 | 436,550 | 402,016 | 374,486 | 459,216 | 456,855 | 402,399 | 439,078 | 447,140 | 347,593 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 536 | 536 | 0 |
other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other current liabilities | 475,590 | 253,950 | 406,757 | 1,070,314 | 554,340 | 210,788 | 238,091 | 144,498 | 0 | 0 | 0 | 0 | 0 | 0 |
total current liabilities | 1,265,822 | 885,889 | 1,128,381 | 1,677,179 | 1,026,809 | 647,338 | 640,107 | 518,984 | 459,216 | 456,855 | 402,399 | 439,614 | 447,676 | 347,593 |
loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
provisions | 85,103 | 90,249 | 78,876 | 17,428 | 17,428 | 3,186 | 8,156 | 7,122 | 5,917 | 9,143 | 12,444 | 14,786 | 16,369 | 14,847 |
total long term liabilities | 85,103 | 90,249 | 78,876 | 17,428 | 17,428 | 3,186 | 8,156 | 7,122 | 5,917 | 9,143 | 12,444 | 14,786 | 16,369 | 14,847 |
total liabilities | 1,350,925 | 976,138 | 1,207,257 | 1,694,607 | 1,044,237 | 650,524 | 648,263 | 526,106 | 465,133 | 465,998 | 414,843 | 454,400 | 464,045 | 362,440 |
net assets | 3,959,919 | 4,192,606 | 4,284,566 | 4,255,367 | 3,986,667 | 3,973,359 | 3,888,600 | 3,918,380 | 4,094,673 | 4,239,392 | 4,371,490 | 4,668,003 | 4,824,741 | 4,799,936 |
total shareholders funds | 3,959,919 | 4,192,606 | 4,284,566 | 4,255,367 | 3,986,667 | 3,973,359 | 3,888,600 | 3,918,380 | 4,094,673 | 4,239,392 | 4,371,490 | 4,668,003 | 4,824,741 | 4,799,936 |
Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 | Jun 2016 | Jun 2015 | Jun 2014 | Jun 2013 | Jun 2012 | Jun 2011 | Jun 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | ||||||||||||||
Operating Profit | ||||||||||||||
Depreciation | 97,085 | 116,534 | 46,428 | 44,694 | 37,223 | 5,676 | 4,159 | 22,734 | 27,150 | 28,558 | 25,407 | 25,151 | 19,115 | |
Amortisation | 187,500 | 187,500 | 187,500 | 187,500 | 187,500 | 187,500 | 187,500 | 187,500 | 187,500 | 187,500 | 187,500 | 0 | 0 | |
Tax | ||||||||||||||
Stock | 99,486 | -32,126 | 43,167 | -7,054 | 92,040 | 21,896 | 46,046 | -24,576 | -7,714 | 3,203 | 9,638 | -5,407 | 9,046 | 159,439 |
Debtors | 323,142 | -173,958 | 166,976 | -143,101 | 201,880 | 54,327 | 12,898 | 85,025 | -40,778 | -12,371 | 25,365 | -20,532 | 29,975 | 362,225 |
Creditors | 158,293 | -89,685 | 114,759 | 134,396 | 35,919 | 34,534 | 27,530 | -84,730 | 2,361 | 54,456 | -36,679 | -8,062 | 99,547 | 347,593 |
Accruals and Deferred Income | 221,640 | -152,807 | -663,557 | 515,974 | 343,552 | -27,303 | 93,593 | 144,498 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes & Provisions | -5,146 | 11,373 | 61,448 | 0 | 14,242 | -4,970 | 1,034 | 1,205 | -3,226 | -3,301 | -2,342 | -1,583 | 1,522 | 14,847 |
Cash flow from operations | ||||||||||||||
Investing Activities | ||||||||||||||
capital expenditure | ||||||||||||||
Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
cash flow from investments | ||||||||||||||
Financing Activities | ||||||||||||||
Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -536 | 0 | 536 | 0 |
Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
share issue | ||||||||||||||
interest | ||||||||||||||
cash flow from financing | ||||||||||||||
cash and cash equivalents | ||||||||||||||
cash | -23,375 | 13,854 | -754,095 | 1,301,419 | 285,493 | 103,576 | 207,202 | 29,027 | 96,223 | 142,875 | -169,015 | 132,717 | 68,793 | 30,592 |
overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
change in cash | -23,375 | 13,854 | -754,095 | 1,301,419 | 285,493 | 103,576 | 207,202 | 29,027 | 96,223 | 142,875 | -169,015 | 132,717 | 68,793 | 30,592 |
P&L
June 2023turnover
5.3m
+33%
operating profit
-306.5k
0%
gross margin
30.9%
-5.14%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
June 2023net assets
4m
-0.06%
total assets
5.3m
+0.03%
cash
1.5m
-0.02%
net assets
Total assets minus all liabilities
abbey chemists ltd company details
company number
SC323221
Type
Private limited with Share Capital
industry
47730 - Dispensing chemist in specialised stores
incorporation date
May 2007
age
17
accounts
Total Exemption Full
ultimate parent company
previous names
N/A
incorporated
UK
address
c/o alexander sloan, 7th floor,, st. vincent street, glasgow, G2 5SG
last accounts submitted
June 2023
abbey chemists ltd Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 1 charges/mortgages relating to abbey chemists ltd. Currently there are 0 open charges and 1 have been satisfied in the past.
abbey chemists ltd Companies House Filings - See Documents
date | description | view/download |
---|